Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Quinn

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Interventions in Aging|February 12, 2024
Comprehensive Geriatric Assessment in the Emergency Department: A Prospective Cohort Study of Process, Clinical, and Patient-Reported OutcomesÍde O'Shaughnessy, Katie Robinson, Aoife Whiston, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Oncotarget|October 1, 2019
The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumorJamie M Aye, Laura L Stafman, Adele P Williams, et al.
Neurology|May 11, 2022
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth DiseaseFlorian P Thomas, Thomas H Brannagan, Russell J Butterfield, et al.
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
The Journal of Clinical Investigation|March 23, 2021
Pathogenic variants in TNNC2 cause congenital myopathy due to an impaired force response to calciumMartijn van de Locht, Sandra Donkervoort, Josine M de Winter, et al.
Brain : a Journal of Neurology|October 29, 2014
Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysisSilvia Corrochano, Roope Männikkö, Peter I Joyce, et al.
EMBO Molecular Medicine|December 3, 2020
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosisKaterina Placek, Michael Benatar, Joanne Wuu, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Interventions in Aging|February 12, 2024
Comprehensive Geriatric Assessment in the Emergency Department: A Prospective Cohort Study of Process, Clinical, and Patient-Reported OutcomesÍde O'Shaughnessy, Katie Robinson, Aoife Whiston, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Oncotarget|October 1, 2019
The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumorJamie M Aye, Laura L Stafman, Adele P Williams, et al.
Neurology|May 11, 2022
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth DiseaseFlorian P Thomas, Thomas H Brannagan, Russell J Butterfield, et al.
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
The Journal of Clinical Investigation|March 23, 2021
Pathogenic variants in TNNC2 cause congenital myopathy due to an impaired force response to calciumMartijn van de Locht, Sandra Donkervoort, Josine M de Winter, et al.
Brain : a Journal of Neurology|October 29, 2014
Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysisSilvia Corrochano, Roope Männikkö, Peter I Joyce, et al.
EMBO Molecular Medicine|December 3, 2020
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosisKaterina Placek, Michael Benatar, Joanne Wuu, et al.
The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Pageof 7